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Liquid–liquid  extraction  (LLE)  is the  most  commonly  sample  preparation  procedure  used  by
forensic  toxicologists  in  China  for  screening  drugs  in  whole  human  blood.  It  extracts  numer-
ous substances  from  blood  including  targeted  drugs  and  interfering  substances,  speciﬁcally
triglycerides  (TG).  With  increasing  prevalence  of  hyperlipidemia,  the  inﬂuences  of  TG  on
LLE and  on subsequent  analysis  with  gas  chromatography–mass  spectrometry  (GC–MS)
may  become  a major  issue  for  forensic  laboratories.  This  study  aims  to  elucidate  the  inﬂu-
ences of TG  on  LLE and to provide  possible  solutions  to this  problem.  Nineteen  commonly
encountered  drugs  in  forensic  cases  were  spiked  to  human  whole  blood  with  different
TG  concentrations.  Diethyl  ether,  ethyl  acetate/hexane  mixed  solutions,  chlorobutane  and
several  other  frequently  used  solvents  were tested  for  the extraction  of  drugs  from  spiked
whole  blood.  The  supernatant  organic  layer  was  evaporated  to  dryness  and  reconstituted
with  methanol.  The  resultant  products  were  analyzed  by GC–MS,  and  the  extraction  recov-
ery was  calculated.  LLE with  diethyl  ether,  ethyl  acetate/hexane  (9:1)  and  chlorobutane
all  possessed  effective  and reliable  extraction  recoveries  for blood  sample  with  low  TG
concentrations  (0.63–6.85  mmol/L).  At high  TG concentrations,  diethyl  ether  produced  a
highly turbid  substance  that  could  not  be further  analyzed  using  GC–MS.  Extraction  recov-
eries  drastically  dropped  for ethyl  acetate/hexane  (9:1)  mixture  at high  TG  concentrations,lenbuterol (PubChem CID: 2783)
iphenoxylate (PubChem CID: 13505)
hlorobutane (PubChem CID: 8005)
while  chlorobutane  experienced  minimal  drops  in extraction  recoveries.  In  conclusion,  TG
levels  in  whole  blood  noticeably  inﬂuence  drug  recovery  to  variable  extents  depending  on
the LLE  solvent.  Chlorobutane  showed  minimal  inﬂuences  from  TG  content  in whole  blood
and thus  is the  recommended  LLE  solvent  for forensic  drug  extraction.
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the  CC  BY-NC-N
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1. Introduction
Human whole blood is a ubiquitous sample in the ﬁeld
of forensic toxicology. The most common procedure of
choice for pretreating whole blood is initial pretreatment
by liquid–liquid extraction (LLE). Because of its suitability
for screening, ease of operation, low cost, and adaptability
is is an open access article under the CC BY-NC-ND license
logy Reports 2 (2015) 785–791
Table 1
Retention time and fragment ions of the 19 drugs chosen to be spiked into
human whole blood.
Drug Retention time
(RT) (min)
Signiﬁcant ions
(m/z)
Spiked
concentration
(g/mL)
AMP  4.30 44/91/65 5.0
MAMP 4.55 58/91/149 5.0
MDA  6.20 44/136/179 5.0
MDMA  6.45 58/135/193 5.0
Pethidine 7.60 71/247/172 5.0
Secobarbital 7.80 168/195/124 5.0
Ketamine 8.25 180/209/152 5.0
Lidocaine 8.30 86/58/234 5.0
Clenbuterol 9.20 86/57/127 5.0
Benzhexol 10.20 98/218/118 5.0
Carbamazepine 10.60 193/236/165 5.0
Diazepam 11.20 256/283 5.0
Chlorpromazine 11.50 58/86/318 5.0
Olanzapine 13.35 242/229/312 5.0
Flurazepam 13.65 86/99/387 5.0
Clozapine 14.9 243/256/192 5.0
Alprazolam 16.0 279/204/308 5.0
Triazolam 17.6 313/238/342 5.0
Diphenoxylate 27.8 246/42/91 7.5786 Z. Huang et al. / Toxico
[17], LLE is accredited as the standard technique to pre-
treat whole blood from forensic cases for drug and poison
detection in China.
In LLE, an extraction solvent is used to extract and purify
the analytes out of whole blood to be further analyzed. One
main parameter for assessing LLE efﬁcacy is the extraction
recovery of targeted analytes. Other parameters that need
to be considered include the extraction solvent’s speciﬁcity,
volatility and toxicity [5]. Unfortunately, extraction sol-
vents often can extract additional endogenous substances,
such as triglyceride (TG) [14], which may  interfere with
subsequent analysis [1]. With increasing prevalence of
hypertriglyceridemia in China (up to 11.3% for individuals
over 18 years old) [11,12], the level of TG is now more
likely to affect the detection of drugs in whole blood. It
was believed the saturated fatty acid chains of TG showed
afﬁnity to form tight bonds with certain drugs, depending
on chemical structure and polarity of the drug. This could
result in formation of complexes that cannot be extracted
efﬁciently by LLE solvents [7,8]. This study hypothesizes
that high TG levels can reduce the extraction recoveries of
drugs when using LLE.
The primary purpose of this study was to determine the
impact of TG content on LLE for human whole blood. This
study also attempts to ﬁnd an alternative extraction solvent
that can counteract the negative impacts of TG.
2. Materials and methods
2.1. Chemicals and solutions
Amphetamine (AMP), methamphetamine (MAMP), 3,4-
methylenedioxyamphetamine (MDA), 3,4-methylenedi-
oxymethamphetamine (MDMA), ketamine, methadone,
pethidine, secobarbital, lidocaine, clenbuterol, benzhexol,
carbamazepine, diazepam, chlorpromazine, olanzapine,
ﬂurazepam, clozapine, alprazolam, triazolam and diphe-
noxylate were purchased from the National Institute for
Control of Pharmaceutical and Biological Products (Bei-
jing, PR China). HPLC grade chlorobutane was  obtained
from Sigma–Aldrich Co., Ltd. (St. Louis, USA). Analytical
grade ethyl acetate, hexane, cyclohexane, heptane, isooc-
tane, sodium hydroxide (NaOH) and HPLC grade methanol
were purchased from Sinopharm Chemical Reagent Co.,
Ltd. (Shanghai, China).
2.2. Instrumentation and chromatographic conditions
The chromatographic system used was an Agilent 7890
GC. It was ﬁtted with a 5975C mass detector (MSD) (Agi-
lent Technologies, Palo Alto, CA, USA) and connected to HP
Chemstation software for data recording.
Separations were conducted on a HP-5MS capillary
column (30 m × 0.25 mm × 0.25 m)  (Agilent Technolo-
gies, Palo Alto, CA, USA). 1 L of sample was injected in
split mode (split ratio = 10:1) using an ionizing energy of
70 eV with temperatures of the inlet, MSD  transfer line,
quadrupole and ion source at 250 ◦C, 280 ◦C, 150 ◦C and
230 ◦C, respectively. Temperature of the column was  set at
100 ◦C initially, maintained for 1 min  and increased at a rate
of 20 ◦C/min to 280 ◦C, which was kept constant for 23 min.AMP, amphetamine; MAMP,  methamphetamine; MDA, 3,4-
methylenedioxyamphetamine; MDMA,  3,4-methylenedioxymetham-
phetamine.
Helium was  used as the carrier gas at a constant ﬂow rate
of 1 mL/min for a total GC runtime of 33 min. There was  a
3 min  solvent delay before the ion source was turned on.
Selected ion monitoring (SIM) mode was utilized to collect
chromatograms. Two  or three fragment ions were used for
each compound (Table 1).
2.3. Specimen
Whole blood samples for preliminary experiments were
leftover blank blood from forensic cases. Hypertriglyc-
eridemia whole blood samples were obtained from 96
volunteers, and they were divided into 5 groups accord-
ing to TG concentrations, which were measured with a
Hitachi 7600-120 Model Automatic Analyzer. Overall TG
concentration ranged from 0.60 mmol/L to 33.35 mmol/L.
All samples were stored at −20 ◦C for 2 months prior to
LLE.
2.4. Sample preparation
2 mL  of human whole blood was initially spiked with
19 drugs each reaching a concentration of 5 g/mL except
diphenoxylate which reached 7.5 g/mL. 3 mL  of extraction
solvent was  then added to the sample. The samples were
mixed for 2 min  followed by centrifugation at 4000 RPM
for 5 min. The supernatant organic layer was collected.
200 l of NaOH (10%) and 3 mL  of the same extraction sol-
vent used previously were added to the pellet remaining
from centrifugation. The samples were again mixed for
2 min  followed by centrifugation at 4000 RPM for 5 min.
The supernatant organic layer was collected and combined
with the previously collected supernatant. The combined
supernatant was then evaporated to dryness under air at
50 ◦C. The residue was reconstituted in 100 L of methanol,
of which 1 L was injected into the GC–MS system. The
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Table  2
Recoveries of most common drugs for comparison between extraction solvents.
Chlorobutane Diethyl ether Ethyl acetate Heptane Hexane Isooctane
Diazepam 56.3% 46.9% 65.1% 38.8% 22.1% 14.3%
Chlorpromazine 47.9% 42.6% 36.7% 23.2% 3.2% 8.4%
Flurazepam 59.2% 47.5% 52.6% 38.4% 4.4% 15.8%
Clozapine 50.1% 45.5% 60.5% 24.5% 34.8% 1.3%
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xtraction recovery values were calculated by comparing
he peak areas of the analytes extracted from whole blood
o the areas obtained by injecting the standard solutions at
he same concentrations.
.5. Statistical analysis
Statistical analyses in this study were conducted using
tatistical Product and Service Solutions (SPSS) version
5.0.
. Results and discussion
.1. Preliminary selection of organic solvents
The organic solvents used for the extraction of drugs in
uman whole blood were selected based on frequency of
sage in research and blood detection in forensic practice
2–4,13,15,16,18–21,23], and on their corresponding tox-
cities. Thus, solvents of high toxicity such as benzene,
hloroform and dichloromethane were not included in our
ist despite favorable extraction efﬁciency. Our preliminary
ist contained pure solvents (diethyl ether, chlorobutane,
exane, ethyl acetate, heptane, and isooctane), and mixed
olutions (chlorobutane/isopropanol solution and ethyl
cetate/hexane solution). These extraction solvents were
valuated based on recoveries using the same spiked whole
lood..1.1. Evaluation of pure solvent
Six pure solvents were studied, and it was found that,
he extraction solvents that possessed the highest and most
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Fig. 1. Mass spectrum of pure ethyl acetat.6% 0.10% 56.4% 0.12%
.8% 44.9% 12.3% 2.7%
.8% 0.6% 0.10% 0.08%
consistent recoveries were chlorobutane, diethyl ether and
ethyl acetate (Table 2). Hexane possessed low recovery
speciﬁcally for chlorpromazine, ﬂurazepam, and carba-
mazepine, while heptane and isooctane possessed low
recovery for alprozolam and chlorpromazine. Although
heptane, hexane and isooctane are commonly used as the
extraction solvents in other researches, we believe their
weak polarities constitute to their low recoveries, making
them unsuitable for LLE. Thus, chlorobutane, ethyl acetate
and diethyl ether were selected as the extraction solvents
for further testing.
3.1.2. Evaluation of ethyl acetate/hexane mixed solutions
For ethyl acetate/hexane solution, the ratio of ethyl
acetate to hexane varied greatly in research [15,21] and
required a selection of an optimal mixture. The recover-
ies for pure ethyl acetate were compared to those of ethyl
acetate/hexane mixture at ratios of 2:1, 6:1 and 9:1. The
results showed little difference between pure ethyl acetate
and three ethyl acetate/hexane mixtures, showing a rel-
ative standard deviation (RSD) lower than 11.1%. Using
MDMA  as an example, the recovery was  51.5% when using
ethyl acetate alone, and 51.7%, 49.2% and 51.3% at ratios
of 2:1, 6:1, 9:1, respectively (RSD = 2.2%, n = 4). The only
notable improvement was  the 70% increase in extraction
recovery for chlorpromazine by ethyl acetate/hexane mix-
ture at 9:1.Furthermore, from the gas chromatogram, we discov-
ered that the ethyl acetate/hexane mixtures consistently
produced signiﬁcantly lower background noise than pure
ethyl acetate from impurities (Fig. 1). This phenomenon
11.211.010.810.610.410.2
e versus ethyl acetate/hexane 9:1.
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was most recognizable for column bleeding at retention
time 5.2 min. We  believed that the addition of hexane
to ethyl acetate helped protect the gas chromatographic
column but further investigation would be required for
conﬁrmation.
Therefore, ethyl acetate/hexane mixed solution (9:1)
replaced pure ethyl acetate in further testing.
3.1.3. Evaluation of chlorobutane/isopropanol (4:1)
mixed solution
We discovered that the addition of chlorobutane to
blood followed by mixing often resulted in emulsiﬁca-
tion of the sample. This phenomenon formed a thick,
turbid layer that effectively trapped and prevented the
drugs from separating into the supernatant organic layer
during centrifugation. As a result, the drugs remained
in the pellet and recoveries drop drastically. To deal
with this problem, chlorobutane/isopropanol (4:1) mixture
was used instead of pure chlorobutane [20]. Isopropanol
acted as a de-emulsiﬁer and subsequent mixing effectively
counteracted the emulsiﬁcation. However, this mixed
solution produced varying results for drug recoveries.
The mixed solution reduced recoveries for MDMA,  clen-
buterol, carbamazepine, clozapine and alprazolam while
only increasing recoveries for MDA  and diphenidol. Fur-
thermore, the mixed solution produced more background
noise on chromatogram than pure chlorobutane. There-
fore, pure chlorobutane was preferable for further testing.
In regards to emulsiﬁcation, saturated salt water equal to
the amount of chlorobutane was added to the emulsiﬁed
substance. Subsequent mixing and centrifugation counter-
acted emulsiﬁcation while also preserving recoveries.
3.2. Effect of TG concentration on the extraction recovery
when using diethyl ether, ethyl acetate/hexane mixture
and chlorobutane as the extraction solvents
19 drugs spiked to whole blood samples with varying
TG concentrations were extracted by the solvents obtained
from preliminary selection, and the recoveries were com-
pared.
3.2.1. Diethyl ether as the extraction solvent
Under low TG concentrations (1.67, 3.79, and
6.87 mmol/L), diethyl ether produced recoveries ranging
from 11.7% to 81.1%, and 16 out of 19 drugs had consistent
recoveries above 50%. The recovery data was highly
precise. The RSDs of the recoveries for MDA, MDMA,
carbamazepine, chlorpromazine, clozapine and diphe-
noxylate were 7.6%, 11.3%, 11.4%, 14.1%, 16.2% and 16.2%
respectively for the three trials. However, diethyl ether
produced low recoveries for olanzapine, AMP, and MAMP
at 32.7% (RSD = 16.8%, n = 3), 21.3% (RSD = 35.0%, n = 3)
and 11.7% (RSD = 47.9%, n = 3) respectively. Regarding the
poor recovery associated with amphetamines, we, as well
as other researchers, have observed this phenomenon
where amphetamines are extremely volatile by nature and
can easily evaporate along with the supernatant during
evaporation [9,10,22].
In this study, diethyl ether consistently produced seri-
ous procedural problems when pretreating whole bloodorts 2 (2015) 785–791
under high TG concentrations. This problem occurred
for all trials with TG concentrations of 11.43 mmol/L,
15.06 mmol/L, 19.76 mmol/L and 26.78 mmol/L. Evapora-
tion of the supernatant organic layer to dryness after LLE
with diethyl ether resulted in a brownish yellow, turbid and
oily substance that could not reconstitute in methanol. This
resulted in a turbid mixture which could not be injected
for further instrumental analysis. In fact, this phenomenon
has been frequently encountered in routine practice dur-
ing forensic blood analysis in our lab. In certain cases such
as hemorrhagic shock and cardiac rupture, the collected
blood sample is extremely scarce, sometimes less than
2 mL.  According to the standard protocol, a 2 mL  of sample
can supply enough blood for only one analytical procedure.
Thus, if the extracted residue becomes turbid after LLE with
diethyl ether, the blood analysis would become inconclu-
sive as there may  be inadequate blood left for additional
analysis. Therefore, diethyl ether can only be used reliably
for whole blood sample with low TG concentrations.
3.2.2. Ethyl acetate/n-hexane mixture (9:1) as the
extraction solvent
At low TG concentrations ranging from 1.12 to
6.85 mmol/L, ethyl acetate/hexane (9:1) mixed solution
consistently produced high recoveries, especially for
MAMP,  clozapine, lidocaine, ketamine, carbamazepine
and chlorpromazine, which averaged to 90.5 ± 4.7%,
91.5 ± 3.6%, 91.7 ± 2.7%, 94.5 ± 3.0%, 92.7 ± 5.7% and
91.5 ± 4.6%, respectively. However, a rise in TG concentra-
tion resulted in dramatic drops in recoveries (Fig. 2). This
was  especially evident in the highest TG concentration
of 23.35 mmol/L where recoveries dropped for all 19
drugs. This showed that high TG concentrations could
dramatically reduce the recoveries when using ethyl
acetate/hexane (9:1) mixed solution.
3.2.3. Chlorobutane as the extraction solvent
Chlorobutane produced the most consistent and reli-
able drug recoveries at all levels of TG concentration. Most
drugs produced recoveries ranging from 30.3% to 85.8%,
with the exception of four amphetamines (AMP, MAMP,
MDA and MDMA)  at any TG concentrations and of olanza-
pine at high TG concentrations (Table 3). These reduced
recoveries for the amphetamines were also found in a
study by Demme  where chlorobutane was  used to extract
over 200 drugs from water [6]. Demme  discovered that
chlorobutane was  an extremely potent extraction solvent
for most drugs except amphetamines. As previously men-
tioned for diethyl ether, this was likely due to the loss
of amphetamines during evaporation. The recoveries for
most drugs only dropped minimally with increasing TG
concentration. Most notable among varying TG concentra-
tions were for dolantin, ketamine, lidocaine, clenbuterol,
diazepam, ﬂurazepam and triazolam whose recovery RSDs
were only 13.9%, 15.4%, 13.6%, 13.2%, 15.6%, 15.6% and
16.5%, respectively. However, the extraction recoveries of
olanzapine dropped to 1.0% and 3.6% when TG concen-
tration reached 15.06 and 33.35 mmol/L. The non-polar
piperazine ring of olanzapine may  strengthen the afﬁnity
of the drug to bind to the saturated fatty acid chains of TG.
This resulted in the formation of drug-TG complexes that
Z. Huang et al. / Toxicology Reports 2 (2015) 785–791 789
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ould not be extracted by LLE. Thus, olanzapine showed
rastically reduced recoveries under high TG concentra-
ions. Meanwhile, secobarbital, clenbuterol, diphenoxylate
lso possessed relatively low recoveries, which averaged
5.6% (RSD = 23.8%, n = 8), 55.0% (RSD = 13.2%, n = 8), and
0.3% (RSD = 30.3%, n = 8), respectively. The 2-pentyl group
nd the 3-propenyl group of secobarbital, the tert-butyl
roup of clenbuterol and the tetrahydropyridine structure
f diphenoxylate increased each of their overall lipophilic-
ty. Thus, we believe these drugs were also more likely
o bind to TG to form complexes that could not be effec-
ively extracted, resulting in decreased recoveries. These
able 3
ecovery of 19 drugs at varying TG concentrations using chlorobutane.
Drugs TG concentration (mmol/L) 
0.63 1.47 1.99 2.24 3.81
AMP 32.2 18.4 35.4 35.8 33.4
MAMP  32.3 16.6 32.3 37.3 49.2
MDA  3.6 8.6 18.7 43.7 29.8
MDMA  12.4 46.0 67.5 57.0 69.4
Pethidine 63.4 71.1 82.6 76.0 86.4
Secobarbital 40.6 44.5 49.8 42.6 48.7
Ketamine 60.8 75.6 88.5 72.7 86.2
Lidocaine 69.6 85.7 95.5 80.9 92.7
Clenbuterol 46.6 57.0 65.2 53.5 62.1
Benzhexol 71.1 80.0 83.4 72.2 85.6
Carbamazepine 55.6 74.4 77.8 61.2 66.5
Diazepam 73.2 87.6 96.8 78.9 89.3
Chlorpromazine 67.8 70.8 74.2 67.2 71.9
Olanzapine 38.7 63.3 79.4 44.3 23.4
Flurazepam 71.3 83.9 92.6 78.2 85.8
Clozapine 69.5 92.8 109.4 75.3 82.2
Alprazolam 66.7 86.6 95.6 75.5 83.4
Triazolam 65.6 78.9 86.5 68.4 76.5
Diphenoxylate 25.9 30.3 39.7 28.6 31.7
G, triglycerides; RSD, relative standard deviation; AMP, amphetamine; MAMP
,4-methylenedioxymethamphetamine.sing ethyl acetate/n-hexane (9:1) mixed solution.
results suggested the extraction efﬁcacy of chlorobutane
was thwarted by TG levels only toward speciﬁc drugs
such as olanzapine but remained consistent for most other
drugs.
3.2.4. Cross comparison of diethyl ether, ethyl
acetate/n-hexane and chlorobutane
For a particular blood sample, the recoveries of all
19 drugs were horizontally compared for diethyl ether,
chlorobutane and ethyl acetate/hexane (9:1) mixed solu-
tion by extracting chemically stable drugs, particularly
diazepam and benzhexol (Table 4). The recoveries of the
Mean RSD (%)
 7.04 15.06 26.78
 31.9 6.5 29.4 26.4 38.8
 30.3 31.2 29.4 30.3 29.8
 46.0 0.2 49.9 23.0 87.2
 38.7 32.9 75.7 48.9 44.0
 95.6 79.5 65.7 78.0 13.9
 62.2 44.1 23.4 45.6 23.8
 97.2 80.3 65.8 78.6 15.4
 102.3 83.6 70.0 85.8 13.6
 53.2 44.0 58.8 55.0 13.2
 102.9 77.7 53.2 77.5 18.3
 89.8 60.1 49.6 68.2 19.2
 99.8 73.6 62.2 82.6 15.6
 83.1 49.3 40.9 65.0 21.2
 80.7 1.0 3.6 45.0 69.6
 100.5 70.0 62.1 81.4 15.6
 117.2 54.9 57.4 83.8 27.2
 105.8 75.5 59.4 82.5 18.3
 91.3 68.1 52.6 75.0 16.5
 74.4 36.2 15.2 30.3 24.7
, methamphetamine; MDA, 3,4-methylenedioxyamphetamine; MDMA,
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Table 4
Recoveries of diazepam and benzhexol at four TG concentrations obtained using diethyl ether, ethyl acetate/hexane mixed solution (9:1) and chlorobutane
as  the extraction solvents.
Diazepam Benzhexol
TG  concentration (mmol/L) 1.67 3.79 6.87 7.75 1.67 3.79 6.87 7.75
82.0% 
76.6%
71.4% 
[
[
[
[
[
[
[Diethyl ether 57.7% 69.6% 
Ethyl  acetate/hexane mixture (9:1) 76.0% 73.1%
Chlorobutane 81.3% 76.4% 
drugs extracted by the three extraction solvents differed
negligibly in samples with TG concentrations ranging
from 3.79 mmol/L to 6.87 mmol/L. Diethyl ether showed
lower recoveries for diazepam and benzhexol than the
other two solvents in samples with TG concentration at
1.67 mmol/L and 7.75 mmol/L (Table 4). When TG concen-
tration was above 6.87 mmol/L, recoveries obtained using
diethyl ether as the extraction solvent declined drastically,
which suggested that diethyl ether was greatly affected by
TG concentration. Chlorobutane, on the other hand, pro-
duced the most consistent recoveries for all drugs even
at high TG concentrations (Table 3), thus making it the
extraction solvent of choice when facing unknown or high
concentrations of TG in human whole blood.
4. Conclusions
Initial ﬁndings showed that ethyl ether, ethyl acetate
and chlorobutane produced higher recoveries than hex-
ane, heptane and isooctane. Furthermore, the addition of
hexane to ethyl acetate drastically reduced background
noise in gas chromatogram while maintaining recover-
ies. Therefore, diethyl ether, ethyl acetate/n-hexane (9:1)
and chlorobutane were compared with respect to their
ability to extract drugs from human whole blood under
different TG concentrations. Extraction by diethyl ether
performed well for blood samples with low TG con-
centrations, but often formed turbid residues when TG
concentrations were high, which prevented further instru-
mental analysis. Ethyl acetate/hexane (9:1) mixed solution
also effectively extracted all 19 drugs from blood samples
with low TG concentrations but recoveries drastically fell
with increases in TG concentration. Finally, chlorobutane
effectively and reliably extracted most drugs, except the
amphetamines, from blood samples with TG content in the
range of 0.63–26.78 mmol/L. The amphetamines typically
possessed low recovery and therefore traditional LLE might
not be suitable for the extraction of amphetamines from
whole blood samples. Chlorobutane sporadically formed an
emulsiﬁed substance that drastically decreased recovery
when mixed with blood. However, the addition of satu-
rated salt water effectively eliminated the emulsiﬁcation
and restored recovery. Despite this drawback of chlorobu-
tane, it still produced reliable and consistent recovery for
drugs spiked to whole blood at varying TG concentrations.
Therefore, we recommended chlorobutane as the primary
extraction solvent for LLE pretreatment of human whole
blood for forensic purposes.Conﬂict of interest
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[58.4% 56.8% 68.4% 82.0% 58.2%
87.6% 80.1% 75.6% 79.2% 90.9%
98.6% 82.4% 73.3% 73.2% 84.0%
Transparency document
The Transparency document associated with this article
can be found in the online version.
References
[1] M.Y. Ali, R.B. Cole, SFE-plus-C(18) lipid cleanup and selective
extraction method for GC/MS quantitation of polycyclic aromatic
hydrocarbons in smoked meat, J. Agric. Food Chem. 49 (2001)
4192–4198.
[2] A. Alves, M.  Goncalves, M.  Bernardo, B. Mendes, Dispersive
liquid–liquid microextraction of organophosphorous pesticides
using nonhalogenated solvents, J. Sep. Sci. 35 (2012) 2653–2658.
[3] C. Chen, J. Hass, P. Albro, A screening method for polychlorinated
dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and non-ortho
polychlorinated biphenyls (PCBs) in biological matrixes, Environ. Sci.
Technol. 34 (2000) 5172–5176.
[4] Z. Chlobowska, C. Swiegoda, P. Koscielniak, W.  Piekoszewski, Iden-
tiﬁcation and determination of ﬂunitrazepam and its metabolites in
blood by gas chromatography, Chem. Anal. (Wars.) 49 (2004) 71–77.
[5] L. Couchman, P. Morgan, LC-MS in analytical toxicology: some prac-
tical considerations, Biomed. Chromatogr. 25 (2011) 100–123.
[6] U.B.J. Demme, H. Bussemas, T. Daldrup, F. Erdmann, M.  Erkens, P.X.
Iten, H. Käferstein, K.J. Lusthof, H.J. Magerl, A. Meyer Lv Reiter,
G. Rochholz, A. Schmoldt, E. Schneider, H.W. Schültz, T. Stimpﬂ,
F.  Tarbah, J. Teske, W.  Vycudilik, J.P. Weller, W.  Weinmann, Sys-
tematic evaluation of 1-chlorobutane for liquid–liquid extraction
of  drugs, 2005, http://www.gtfch.org/chlorobutaneextraction.pdf,
http://www.gtfch.org/chlorobutaneextraction.pdf
[7] J.A. Donald, BURGER’S Medicinal Chemistry & Drug Discovery, John
Wiley & Sons Inc., 2003.
[8] W.O. Foye, Principles of Medicinal Chemistry, Lea Febiger, Philadel-
phia, 2002.
[9] L. Guo, Z.B. Lin, Z.B. Huang, H. Liang, Y. Jiang, Y.H. Ye, Z.P.
Wu,  R.S. Zhang, Y.R. Zhang, Y.L. Rao, Simple and rapid analy-
sis  of four amphetamines in human whole blood and urine by
liquid–liquid extraction without evaporation/derivatization and by
gas  chromatography–mass spectrometry, Forensic Toxicol. 33 (2015)
104–111.
10] J.M. Holler, S.P. Vorce, T.Z. Bosy, A. Jacobs, Quantitative and iso-
meric determination of amphetamine and methamphetamine from
urine using a nonprotic elution solvent and R(−)-alpha-methoxy-
alpha-triﬂuoromethylphenylacetic acid chloride derivatization, J.
Anal. Toxicol. 29 (2005) 652–657.
11] J.H. Li, S.Q. Mi,  Y.C. Li, M.  Zhang, Y.F. Bi, Y. Jiang, L.M. Wang, G. Ning,
W.H. Zhao, The levels and distribution of the serum lipids in Chinese
adults, 2010, Zhonghua Yu Fang Yi Xue Za Zhi 46 (2012) 607–612.
12] J.H. Li, L.M. Wang, Y.C. Li, Y.F. Bi, Y. Jiang, S.Q. Mi,  M.  Dai, Y. Xu, G.  Ning,
W.H. Zhao, Epidemiologic characteristics of dyslipidemia in Chinese
adults 2010, Zhonghua Yu Fang Yi Xue Za Zhi 46 (2012) 414–418.
13] J. Malakova, H. Brozmanova, V. Vorisek, V. Prochazkova, V. Palicka, A
capillary GC method using nitrogen phosphorus detection for deter-
mination of topiramate in patients with epilepsy, Chromatographia
66 (2007) 363–367.
14] C. Megremis, Medium-chain triglycerides – a nonconventional fat,
Food Technol. 45 (1991) 108–110.
15] J. Owens, D. Holstege, A. Clifford, High-throughput method for the
quantitation of total folate in whole blood using LC-MS/MS, J. Agric.
Food Chem. 55 (2007) 3292–3297.
16] I. Papoutsis, P. Nikolaou, C. Spiliopoulou, C. Pistos, M.  Stefanidou, S.
Athanaselis, A simple and sensitive GC/MS method for the determi-
nation of atropine during therapy of anticholinesterase poisoning in
serum samples, Drug Test. Anal. 4 (2012) 229–234.
17] E. Saar, D. Gerostamoulos, O. Drummer, J. Beyer, Comparison of
extraction efﬁciencies and LC-MS–MS matrix effects using LLE and
ogy Rep
[
[
[
[
[Z. Huang et al. / Toxicol
SPE methods for 19 antipsychotics in human blood, Anal. Bioanal.
Chem. 393 (2009) 727–734.
18] F. Sporkert, C. Brunel, M.  Augsburger, P. Mangin, Fatal tolperisone
poisoning: autopsy and toxicology ﬁndings in three suicide cases,
Forensic Sci. Int. 215 (2012) 101–104.
19] D. Tennakoon, W.  Karunarathna, U. Udugampala, Carbofuran con-
centrations in blood, bile and tissues in fatal cases of homicide and
suicide, Forensic Sci. Int. 227 (2013) 106–110.
20] F. Versace, F. Sporkert, P. Mangin, C. Staub, Rapid sample pre-
treatment prior to GC–MS and GC–MS/MS urinary toxicological
screening, Talanta 101 (2012) 299–306.
[orts 2 (2015) 785–791 791
21] B. Watzer, H. Seyberth, H. Schweer, Determination of misoprostol
free  acid in human breast milk and serum by gas chromatogra-
phy/negative ion chemical ionization tandem mass spectrometry, J.
Mass Spectrom. 37 (2002) 927–933.
22] A. Wohlfarth, W.  Weinmann, S. Dresen, LC-MS/MS screening method
for  designer amphetamines, tryptamines, and piperazines in serum,
Anal. Bioanal. Chem. 396 (2010) 2403–2414.
23] Y. Zhang, H. Lee, Application of ultrasound-assisted emulsiﬁcation
microextraction based on applying low-density organic solvent for
the  determination of organochlorine pesticides in water samples, J.
Chromatogr. A 1252 (2012) 67–73.
